Compare G & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | G | MIR |
|---|---|---|
| Founded | 1997 | 2005 |
| Country | Bermuda | United States |
| Employees | 140000 | 3281 |
| Industry | Professional Services | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.6B |
| IPO Year | 2007 | N/A |
| Metric | G | MIR |
|---|---|---|
| Price | $30.22 | $16.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | ★ $49.50 | $27.25 |
| AVG Volume (30 Days) | 2.5M | ★ 4.1M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | ★ 9.82 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $2,279,438,000.00 | N/A |
| Revenue This Year | $9.20 | $23.95 |
| Revenue Next Year | $7.27 | $7.32 |
| P/E Ratio | ★ $34.90 | $195.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.85 | $15.57 |
| 52 Week High | $48.64 | $30.28 |
| Indicator | G | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 48.01 | 44.63 |
| Support Level | $28.78 | $15.62 |
| Resistance Level | $35.09 | $18.68 |
| Average True Range (ATR) | 0.91 | 0.61 |
| MACD | 0.18 | 0.00 |
| Stochastic Oscillator | 45.99 | 44.39 |
Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.